GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?
Year | Current Liabilities |
---|---|
Mar2025 | - |
Mar2024 | - |
Mar2023 | - |
Mar2022 | - |
Mar2021 | - |
How is Current Liabilities of GLENMARK PHARMACEUTICALS Trending?
Years | Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | - | 0 | |
Mar2024 | - | 0 | |
Mar2023 | - | 0 | |
Mar2022 | - | 0 | |
Mar2021 | - | - |
Compare Current Liabilities of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹54,147.1 Cr | -1.7% | -10.1% | 14.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,388.0 Cr | -2.2% | -8.3% | -13.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,513.0 Cr | -1.1% | -7.3% | 21.6% | Stock Analytics | |
CIPLA | ₹126,733.0 Cr | -0.7% | 1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,292.0 Cr | -0.5% | -4.2% | 4.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,935.0 Cr | -0.5% | -1.1% | -7.7% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -1.7% |
-10.1% |
14.4% |
SENSEX | -1.8% |
-1.6% |
-2% |
You may also like the below Video Courses